
❓ What are the disadvantages of the "one size fits all" approach commonly seen in bladder cancer?
📺 @saumyg speaks on how this can lead to both overtreatment and undertreatment, as well as advances in molecular subtyping and genomics: buff.ly/IyT9GBj
English